Milan, Italy

Clelia Dallanoce

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Flamma S.p.a.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Clelia Dallanoce. Retrieved from https://idiyas.com/inventor/clelia-dallanoce

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Clelia Dallanoce: Inventor of Peptide Derivatives for Oxidative Stress

Introduction

Clelia Dallanoce is an inventor based in Milan, Italy, associated with Flamma S.p.a. Her work includes a patent concerning peptide derivatives designed to address the effects of lipid oxidative stress.

Latest Patents

Dallanoce is named on one patent: Peptide Derivatives and Therapeutic Activity Thereof. The invention describes peptide or pseudopeptide derivatives containing a nitrogenous heterocyclic residue. These compounds are disclosed as having blocking activity against by-products of lipid oxidative stress, particularly unsaturated aldehydes such as malondialdehyde and 4-hydroxy-trans-2-nonenal (HNE). The patent record provided lists 1 patent for Dallanoce.

Career Highlights

Dallanoce’s listed patent reflects research into compounds intended to counter reactive by-products associated with lipid oxidation. Her work is connected with Flamma S.p.a., a company involved in pharmaceutical research and development.

Collaborations

The provided information identifies Stefania Gagliardi and Marco De Amici as Dallanoce’s coworkers. Their names also appear in connection with her professional and patent-related work.

Conclusion

Clelia Dallanoce’s patent work focuses on peptide and pseudopeptide derivatives with potential activity against harmful products of lipid oxidative stress, highlighting her contribution to therapeutic research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…